Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics Employees

As of December 31, 2025, Allogene Therapeutics had 152 total employees, including 150 full-time and 2 part-time employees. The number of employees decreased by 77 or -33.62% compared to the previous year.

• Employees: 152
• Change (1Y): -77
• Growth (1Y): -33.62%
• Revenue / Employee: $30,526
• Profits / Employee: -$1,088,776
• Market Cap: 690.98M

Employees Chart

Chart

Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2025	152	-77	-33.62%	150	2
Dec 31, 2024	229	-4	-1.72%	226	3
Dec 31, 2023	233	-128	-35.46%	232	1
Dec 31, 2022	361	51	16.45%	359	2
Sep 30, 2022	356	55	18.27%	356	0
Jun 30, 2022	344	59	20.70%	344	0
Mar 31, 2022	334	58	21.01%	334	0
Dec 31, 2021	310	45	16.98%	308	2
Sep 30, 2021	301	37	14.02%	301	0
Jun 30, 2021	285	49	20.76%	285	0
Mar 31, 2021	276	61	28.37%	276	0

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Employee data is provided by S&P Global Market Intelligence and updates every three months after the filing of each quarterly report.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error